• 1
    The European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 1998;83: 15071514.DOI: 10.1210/jc.83.5.1507
  • 2
    Santoro N, Filicori M, Crowley Jr WF. Hypogonadotrophic disorders in men and women: diagnosis and therapy with pulsatile gonadotrophin-releasing hormone. Endocrinol Rev 1986;7: 1123.
  • 3
    Silveira LFG, MacColl GS, Bouloux PMG. Hypogonadotrophic hypogonadism. Semin Reprod Med 2002;20: 327338.DOI: 10.1055/s-2002-36707
  • 4
    Levene MI, Wild J, Steer P. Higher multiple births and the modern management of infertility in Britain. Br J Obstet Gynaecol 1992;99: 607613.
  • 5
    Franks S, White DM. Gonadotrophin regimens. In: TempeltonA, CookeI, O'BrienPMS, editors. Evidence-Based Fertility Treatment. London: RCOG Press, The Royal College of Obstetricians and Gynaecologists,1998: 178187.
  • 6
    van Wely M, Westergaard LG, Bossuyt PMM, van der Veen F. Effectiveness of human menopausal gonadotrophin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis. Fertil Steril 2003;80: 10861093.DOI: 10.1016/S0015-0282(03)02187-3
  • 7
    Hughes E, Collins J, Vandekerckhove P, Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotrophin for clomiphene-resistant polycystic ovary syndrome. In: LilfordR, HughesE, VandekerckhoveP, editors. Subfertility Module of the Cochrane Database of Systematic Reviews. London: BMJ Publishing Group,1996: 18.
  • 8
    Daya S, Gunby J, Hughes EG, Collins JA, Sagle MA. Follicle stimulating hormone versus human menopausal gonadotrophin for in vitro fertilization cycles: a meta-analysis. Fertil Steril 1995;64: 347354.
  • 9
    Schoot DC, Harlin J, Shoham Z, et al. Recombinant human follicle stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum Reprod 1994;9: 12371242.
  • 10
    Loumaye E. Ovarian stimulation: is exogenous LH necessary in all patients? Gynecol Obstet Fertil 2002;30: 890895.DOI: 10.1016/S1297-9589(02)00461-7
  • 11
    Porchet HC, Le Cotonnec JY, Neuteboom B, Canali S, Zanolo G. Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone. J Clin Endocrinol Metab 1995;80: 667673.DOI: 10.1210/jc.80.2.667
  • 12
    Chappel SC, Howles C. Re-evaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod 1991;6: 12061212.
  • 13
    Loumaye E, Engrand P, Howles CM, O'Dea L. Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization outcome. Fertil Steril 1997;67: 889899.DOI: 10.1016/S0015-0282(97)81402-1
  • 14
    Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 2002;17: 22872299.DOI: 10.1093/humrep/17.9.2287
  • 15
    Shoham Z, Howles CM, Zalel Y, Weissman A, Insler V. Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism. Hum Reprod 1994;9: 431436.
  • 16
    Agrawal R, West C, Conway GS, Page ML, Jacobs HS. Pregnancy after treatment with three recombinant gonadotrophins. Lancet 1997; 349: 2930.DOI: 10.1016/S0140-6736(97)24027-4
  • 17
    Burgues S. The Spanish Collaborative Group on Female Hypogonadotophic Hypogonadism. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant FSH in WHO group I anovulation: evidence from a multicentre study in Spain. Hum Reprod 2001;16: 25252532.